(Q81227820)
Statements
Design and conduct of phase II studies of targeted anticancer therapy: recommendations from the task force on methodology for the development of innovative cancer therapies (MDICT) (English)
Christopher M Booth
A Hilary Calvert
Marinus W Lobbezoo
Elizabeth A Eisenhauer
Lesley K Seymour
12 September 2007